Greater Indiana Chapter Society for Neuroscience - 2023 Annual Meeting |
September 8, 2023
9:00 a.m. – 6:00 p.m. EDT
Purdue Memorial Union, North Ballroom
|
The Greater Indiana Chapter Society for Neuroscience (GISfN) brings together scientists from across Indiana with a goal to advance the study of the brain, the nervous system and related disorders, promote collaboration and interdisciplinary research, and educate the public and professionals. This annual event provides the largest Indiana venue for networking and sharing research in Neuroscience. We look forward to connecting with you and hearing about your latest exciting results at the 2023 Meeting!
|
2023 Indiana CTSI Annual Meeting |
September 22, 2023
9:00 a.m. – 3:30 p.m. EDT
Hine Hall, 875 West North Street, Indianapolis, IN 46202
|
|
|
Alzheimer’s Disease Pre-clinical Translational Science Grant |
Extended Submission Deadline: August 31, 2023
|
Description: This funding opportunity announcement invites applications from all CTSI investigators with a full-time academic appointment for up to $50,000 to support innovative research work that is in scope and aligned with the research activities of the IUSM-Purdue TREAT-AD Center. These include (but are not limited to):
|
- Bioinformatic analyses and drug target hypothesis generation within neuroinflammatory pathways
-
Target validation studies for proposed drug targets
- Innovative chemical biology and cellular pharmacology studies for proposed targets that provide insights to disease initiation and progression
- Structural biology or biophysical studies on proteins proposed as drug targets
- De-novo drug design approaches for proposed targets
- Novel PET ligands and supporting CSF biomarkers for preclinical studies and clinical trials, etc.
|
|
|
Neuroscience Institute (NSI) Collaborative Pilot Research Grant
|
Submission Deadline: October 31, 2023
|
The overarching goal of the Neurosciences Institute (NSI) Collaborative Pilot Grant is to provide pilot funding to support new research collaborations that will produce preliminary data needed to prepare subsequent research grant applications. Applications may include basic, translational, or clinical neuroscience researchers. Project must be responsive to the scientific mission of the NSI.
This initiative will provide $25,000, per year for a period of up to two years (total funding $50,000); second year of funding will be contingent on progress (as evaluated by the Pilot Grant Committee).
Contact for Questions: Lindsay Treadway
|
|
|
IUSCCC Heme Focused Investigator Initiated Trial (IIT) Pilot Funding |
Notice of Intent Submission Deadline: August 24. 2023
Full Submission Deadline: September 26, 2023
|
The IU Simon Comprehensive Cancer Center (IUSCCC) Hematopoiesis & Hematological Malignancies (HHM) and Experimental & Developmental Therapeutics (EDT) Programs are inviting proposals from members with a focus on hematopoiesis & hematological malignancies focused Investigator Initiated Trials (IITs).
The duration of this pilot funding is one year and the budget should not exceed $100,000.
Investigators wishing to apply to this funding mechanism must first submit a Notice of Intent for approval to Crystal Banks. Once approved, the link for submitting the online application will be sent.
Contact for Questions: Huda Salman or Mat Opyrchal
|
|
|
Must be led by an IUSCCC member
|
IUSCCC Community-Academic Collaborative Program Award |
Letter OF Intent Submission Deadline: Rolling submission
Full Submission Deadline: Rolling submission
|
IU Simon Comprehensive Cancer Center, Office of Community Outreach and Engagement is inviting collaborative proposals for implementing evidence-based cancer related programs within the community. Proposals should focus on the cancer burden in Indiana. The program should have an evaluation component and priority will be given to one of the major cancer burdens in Indiana including lung, breast, colon, pancreas, prostate and cervical. We are particularly interested in programs that can lower risk behaviors related to cancers which drive cancer incidence and morbidity. Of particular interest are community-led programs that will increase our reach or understanding of the underserved populations in Indiana. The project must be co-led by an IUSCCC faculty member and community advocate or partner.
The duration of this funding is one year, and the budget should not exceed $15,000.
Investigators wishing to apply to this funding mechanism must first submit a Letter of Intent for approval to Crystal Baker. Once approved, the link for submitting the online application will be sent.
Contact for Questions: Crystal Baker
|
|
|
IUSCCC “Near-Miss” NIH R01 Initiative |
The IU Simon Comprehensive Cancer Center (IUSCCC) is providing an opportunity to fund cancer focused PI-directed applications to the National Institutes of Health that have been reviewed once and missed the NIH pay line and have a high potential for obtaining external funding. The goal is to increase the cancer focused NIH funding base in the IUSCCC. Non-NCI targeted applications should have significant cancer relevance. This opportunity is limited to those who are IUSCCC members.
Investigators wishing to apply to this funding mechanism must first submit a draft cover letter (letter of intent) for approval by the IUSCCC Executive Committee before working with a Coordinator to submit a full application. Once approved, the link for submitting the online application will be sent.
Maximum allowable amount for R01, R42 and R44 grants is $50K with P01 and SPORE funding amounts evaluated on a case-by-case basis.
Contact for Letter of Intent and Questions: Kaitlin Condron or Crystal Baker
|
|
|
If you have any questions about Indiana CTSI grants, programs, or upcoming events please feel free to reach out to co-navigators Jessica Brookshire or Paul Helquist.
|
|
|
The Indiana CTSI includes Indiana University, Purdue University, and the University of Notre Dame as the major academic partners along with a number of other institutions and entities in the state.
It is funded by a Clinical and Translational Sciences Award from the National Institutes of Health amounting to some $38 million for the current seven-year funding period of 2023-2030. This funding is supplemented by additional support from many other institutional and corporate partners.
Funding is provided to researchers by many mechanisms to promote translational and collaborative research among the partner institutions.
For more information, please visit: indianactsi.org
|
|
|
Manage your preferences | Opt Out using TrueRemove™
Got this as a forward? Sign up to receive our future emails.
View this email online.
|
317 Main Building | Notre Dame, IN 46556 US
|
|
|
This email was sent to .
To continue receiving our emails, add us to your address book.
|
|
|
|